Nevro Corp
NYSE:NVRO
Nevro Corp
EPS (Diluted)
Nevro Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nevro Corp
NYSE:NVRO
|
EPS (Diluted)
-$3
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
EPS (Diluted)
$13
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Nevro Corp
Glance View
Nevro Corp. engages in the provision of medical devices. The company is headquartered in Redwood City, California and currently employs 945 full-time employees. The company went IPO on 2014-11-06. The firm has developed and commercialized the Senza spinal cord stimulation (SCS) system. SCS is a neuromodulation platform for the treatment of chronic pain, with the Senza Omnia platform, which is in addition to the Senza family of products. The Company’s solution for chronic pain includes 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain based on what it believes to be the best clinical evidence available. The advantages of its 10 kHz Therapy over traditional SCS include demonstrated superior efficacy data for both leg and back pain, paresthesia free pain relief for patients, anatomical lead placement for physicians, and ability to treat a broader group of chronic pain patients.
See Also
What is Nevro Corp's EPS (Diluted)?
EPS (Diluted)
-3.1
USD
Based on the financial report for Dec 31, 2024, Nevro Corp's EPS (Diluted) amounts to -3.1 USD.
What is Nevro Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-10%
Over the last year, the EPS (Diluted) growth was -20%. The average annual EPS (Diluted) growth rates for Nevro Corp have been 7% over the past three years , 2% over the past five years , and -10% over the past ten years .
